The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Efficacy of radioimmunotherapy-based conditioning with high-dose chemotherapy and autologous stem cell transplantation for transformed lymphoma.
Amrita Y. Krishnan
Honoraria - Spectrum Pharmaceuticals
Marielle Wondergem
No relevant relationships to disclose
Joycelynne Palmer
No relevant relationships to disclose
Avichai Shimoni
No relevant relationships to disclose
Andrew Antony Raubitschek
No relevant relationships to disclose
Auayporn Nademanee
No relevant relationships to disclose
Otto Visser
No relevant relationships to disclose
Jose M Zijlstra
No relevant relationships to disclose
Nicole Tsai
No relevant relationships to disclose
Arnon Nagler
No relevant relationships to disclose
Neil Martin Kogut
No relevant relationships to disclose
Jennifer Simpson
No relevant relationships to disclose
Stephen J. Forman
No relevant relationships to disclose